Benveniste R, Helman JD, Orth DN, et al. Circulating big human prolactin: conversion to small human prolactin by reduction of disulfide bonds. J Clin Endocrinol Metab 1979;48:883–886.
234.
Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 1985;61:258–264.
235.
Fraser IS, Lun ZG, Zhou JP, et al. Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J Clin Endocrinol Metab 1989;69:585–592.
236.
Larrea F, Escorza A, Valero A, et al. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function. J Clin Endocrinol Metab 1989;68:982–987.
237.
Lewis UJ, Singh RN, Sinha YN, et al. Glycosylated human prolactin. Endocrinology 1985;116:359–363.
238.
Markoff E, Lee DW. Glycosylated prolactin is a major circulating variant in human serum. J Clin Endocrinol Metab 1985:1102–1106.
239.
Markoff E, Lee DW, Hollingsworth DR. Glycosated and nonglycosated prolactin in serum during pregnancy. J Clin Endocrinol Metab 1988;67:519–523.
240.
Pellegrini I, Gunz G, Ronin C, et al. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms. Endocrinology 1988;122:2667–2674.
241.
Bole-Feysot C, Goffin V, Edery M, et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225– 268.
242.
Goldsmith PC, Cronin MJ, Weiner RI. Dopamine receptor sites in the anterior pituitary. J Histochem Cytochem 1979;27:1205–1207.
243.
Quigley ME, Judd SJ, Gilliland GB, et al. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979;48:718–720.
244.
Quigley ME, Judd SJ, Gilliland GB, et al. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma. J Clin Endocrinol Metab 1980;50:994–998.
245.
De Leo V, Petraglia F, Bruno MG, et al. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy. Gynecol Obstet Invest 1989;27:94–98.